Pfizer

News

BioNTech bites back after CureVac patent challenge

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself.

News

Sanofi makes low-cost medicines pledge for low-income countr...

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the

News

Pfizer claims new $3.2bn COVID jab deal with US government

Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include Omicron-targeted shots.

News

Pfizer and Roivant launch autoimmune specialist Priovant

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune

News

US panel backs Omicron-targeting vaccines for booster campai...

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according to the FDA's Vaccines and Related Biological Produc

News

Pfizer seeks to overturn three RSV vaccine patents held by G...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts.

BioNTech bites back after CureVac patent challenge

Sanofi makes low-cost medicines pledge for low-income countr...

Pfizer claims new $3.2bn COVID jab deal with US government

Pfizer and Roivant launch autoimmune specialist Priovant

US panel backs Omicron-targeting vaccines for booster campai...

Pfizer seeks to overturn three RSV vaccine patents held by G...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks